Ishai Luz, n/a

Research Associate
Ben Gurion university, Israel

Poster(s):

• (9) Exploring the biodistribution of p53-containing EVs for targeted cancer therapy
  Thursday, April 24, 2025

  12:30 – 14:30 CET

• (260) EVs from PDAC cells harboring mutant p53 can drive tumor microenvironment remodeling and fibroblast activation
  Thursday, April 24, 2025

  12:30 – 14:30 CET

• (321) Neuroblastoma Extracellular Vesicles mediate Blood-Brain-Barrier permeability and carry tight junctions’ proteins cargo
  Thursday, April 24, 2025

  12:30 – 14:30 CET

• (411) Physiological vs. traditional EV administration: improved biodistribution and reduced toxicity with slow-release pumps
  Thursday, April 24, 2025

  12:30 – 14:30 CET

• (903) Enhancing Natural Killer (NK) cells -Derived Extracellular Vesicles (EVs) for Targeted Cancer Immunotherapy via Chimeric Antigen Receptor (CAR) Engineering
  Friday, April 25, 2025

  16:30 – 17:30 CET

• (981) Cancer cells release ubiquitinated PCNA via extracellular vesicles
  Friday, April 25, 2025

  16:30 – 17:30 CET

• (1056) Elucidating the mechanisms underlying the ability of pathogenic Acidovorax temperans and its derived outer membrane vesicles to promote lung cancer progression
  Friday, April 25, 2025

  16:30 – 17:30 CET